British American Tobacco Stock Jumps as FDA Shift Gives Vuse and Velo a Cleaner Read
British American Tobacco didn’t jump on earnings news this time. Instead, shares surged as investors caught a break on both U.S. nicotine regulation and legal headwinds. BATS wrapped up in London at £46.34, notching a 5.82% gain, even as the FTSE 100 edged down 0.04%. The ADR in New York also finished strong at $63.64.